Mieloma Multiple - Mieloma.com

Mieloma Novedades en investigacion octubre 2006

Fuente y mas informacion:
           Thu, 19 Oct 2006 12:36:03 -0500 (CDT)
De: "MMRF SmartBrief "
http://www.multiplemyeloma.org/

    Future Oncol. 2006 Oct
    Thalidomide in multiple myeloma: past, present and future
http://www.ncbi.nlm.nih.gov/entrez/...l=pubmed_docsum
Harousseau JL

    Clin Lymphoma Myeloma. 2006 Sep
    Weekly bortezomib/methylprednisolone is effective and well tolerated in relapsed multiple myeloma
http://www.ncbi.nlm.nih.gov/entrez/...l=pubmed_docsum
Suvannasankha A, Smith GG, Juliar BE, Abonour R

    Bone Marrow Transplant. 2006 Oct 16
    Autologous stem cell transplantation beyond 60 years of age
http://www.ncbi.nlm.nih.gov/entrez/...l=pubmed_docsum
Jantunen E





____________
Guia de Uso - http://www.mieloma.com/v2/uso-del-foro-vf27.html

Ser feliz no significa que todo sea perfecto, quiere decir que has decidido seguir adelante pese a las dificultades.

Mieloma Novedades en investigacion octubre 2006

Fuente y mas informacion:
 The Myeloma Minute - October 17, 2006
http://readtheminute.myeloma.org/
 
*  Inhaled nitrous oxide (Entonox) as a short acting sedative during bone marrow examination.
http://www.blackwell-synergy.com/do...57.2006.00807.x
      Steedman B, Watson J, Ali S, Shields ML, Patmore RD, Allsup DJ.
      Clin Lab Haematol. 2006 Oct;28(5):321-4.

    * Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs)in vitro and after injection of cytokine-matured DCs in myeloma patients
http://www.bloodjournal.org/cgi/content/abstract/108/8/2655?etoc
      Devi K. Banerjee, Madhav V. Dhodapkar, Elyana Matayeva, Ralph M. Steinman, and Kavita M. Dhodapkar
      Blood 2006;108 2655-2661

    * Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications
http://www.bloodjournal.org/cgi/content/abstract/108/8/2804?etoc
      Masood A. Shammas, Paola Neri, Hemanta Koley, Ramesh B. Batchu, Robert C. Bertheau, Vidit Munshi, Rao Prabhala, Mariateresa Fulciniti, Yu tzu Tai, Steven P. Treon, Raj K. Goyal, Kenneth C. Anderson*, and Nikhil C. Munshi
      Blood 2006;108 2804-2810

    * Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study
http://www.bloodjournal.org/cgi/content/abstract/108/8/2867?etoc
      Christopher J. Fraser, Smita Bhatia, Kirsten Ness, Andrea Carter, Liton Francisco, Mukta Arora, Pablo Parker, Stephen Forman, Daniel Weisdorf, James G. Gurney, and K. Scott Baker
      Blood 2006;108 2867-2873

    * The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis
http://www.bloodjournal.org/cgi/con...006-07-032987v1
      Angela Dispenzieri, Martha Q. Lacy, Steven R. Zeldenrust, Suzanne R. Hayman, Shaji K. Kumar, Susan M. Geyer, John A. Lust, Jacob B. Allred, Thomas E. Witzig, S. Vincent Rajkumar*, Philip R. Greipp, Stephen J. Russell, Brian Kabat, and Morie A. Gertz*
      Blood published 28 September 2006, 10.1182/blood-2006-07-032987

    * New agents that stimulate erythropoiesis
http://www.bloodjournal.org/cgi/con...19083v1?papetoc
      H Franklin Bunn
      Blood published 10 October 2006, 10.1182/blood-2006-08-019083

    * PKC412 demonstrates JNK-dependent activity against human multiple myeloma
      cells
http://www.bloodjournal.org/cgi/con...14092v1?papetoc
      Janelle Sharkey, Tiffany Khong, and Andrew Spencer
      Blood published 10 October 2006, 10.1182/blood-2006-05-014092

    * Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma
      (MM)
http://www.bloodjournal.org/cgi/con...15149v1?papetoc
      Dharminder Chauhan, Paola Neri, Mugdha Velankar, Klaus Podar, Teru Hideshima, Mariateresa Fulciniti, Pierfrancesco Tassone, Noopur Raje, Constantine S. Mitsiades, Nicholas Mitsiades, Paul G. Richardson*, Leigh Zawel, Mary Tran, Nikhil C. Munshi, and Kenneth C. Anderson*
      Blood published 10 October 2006, 10.1182/blood-2006-04-015149





____________
Guia de Uso - http://www.mieloma.com/v2/uso-del-foro-vf27.html

Ser feliz no significa que todo sea perfecto, quiere decir que has decidido seguir adelante pese a las dificultades.

Mieloma Novedades en investigacion octubre 2006

Fuente y mas informacion:
          Thu, 12 Oct 2006 12:37:08 -0500 (CDT)
De: "MMRF SmartBrief "
http://www.multiplemyeloma.org/

    Br J Haematol. 2006 Oct
    Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study
http://www.ncbi.nlm.nih.gov/entrez/...l=pubmed_docsum
Berenson JR, Boccia R, Siegel D, Bozdech M, Bessudo A, Stadtmauer E, Talisman Pomeroy J, Steis R, Flam M, Lutzky J, Jilani S, Volk J, Wong SF, Moss R, Patel R, Ferretti D, Russell K, Louie R, Yeh HS, Swift RA

    Best Pract Res Clin Haematol. 2006 Dec
    Thalidomide and lenalidomide in multiple myeloma
http://www.ncbi.nlm.nih.gov/entrez/...l=pubmed_docsum
Mazumder A, Jagannath S.

    Curr Opin Oncol. 2006 Nov
    Beyond single-agent bortezomib: combination regimens in relapsed multiple myeloma
http://www.ncbi.nlm.nih.gov/entrez/...l=pubmed_docsum
Richardson PG, Mitsiades C, Ghobrial I, Anderson K





____________
Guia de Uso - http://www.mieloma.com/v2/uso-del-foro-vf27.html

Ser feliz no significa que todo sea perfecto, quiere decir que has decidido seguir adelante pese a las dificultades.

Mieloma Novedades en investigacion octubre 2006

Fuente y mas informacion:
 Myeloma Minute - October 5, 2006
http://readtheminute.myeloma.org/

    *  Evaluation of five staging systems in 470 patients with multiple myeloma.
http://www.haematologica.org/journal/2006/8/1149.html
      Mihou D, Katodritou I, Zervas K.
      "We evaluated the prognostic significance of five staging systems in 470 consecutive, previously untreated patients with multiple myeloma diagnosed between 1989 and 2006. The five staging systems were those proposed by Durie and Salmon, Bataille et al., the South West Oncology Group, Weber et al. and the International Staging System. This last proved to be superior to the others."
      Haematologica. 2006 Aug;91(8):1149-50.

    *

      Safety and efficacy of risk adapted cyclophosphamide, thalidomide and dexamethasone in systemic AL amyloidosis
http://www.bloodjournal.org/cgi/con...35352v1?papetoc
      Ashutosh D Wechalekar, Hugh J.B. Goodman, Helen J. Lachmann, Mark Offer, Philip N. Hawkins, and Julian D. Gillmore
      Blood published 21 September 2006, 10.1182/blood-2006-07-035352

    *

      STAT3 and MAPK signaling maintains overexpression of the heat shock proteins 90{alpha} and {beta} in multiple myeloma cells, which critically contribute to tumor cell survival
http://www.bloodjournal.org/cgi/con...006-05-024372v1
      Manik Chatterjee, Sarika Jain, Thorsten Stuhmer, Mindaugas Andrulis, Ute Ungethum, Ralf-Jurgen Kuban, Heike Lorentz, Kurt Bommert, Max Topp, Doris Kramer, Hans Konrad Muller-Hermelink, Hermann Einsele, Axel Greiner, and Ralf C Bargou
      Blood published 26 September 2006, 10.1182/blood-2006-05-024372

    *

      Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts
http://www.bloodjournal.org/cgi/con...006-04-016824v1
      Consuelo Gajate and Faustino Mollinedo
      Blood published 26 September 2006, 10.1182/blood-2006-04-016824





____________
Guia de Uso - http://www.mieloma.com/v2/uso-del-foro-vf27.html

Ser feliz no significa que todo sea perfecto, quiere decir que has decidido seguir adelante pese a las dificultades.

Mieloma Novedades en investigacion octubre 2006

Fuente y mas informacion:
    Thu, 5 Oct 2006 13:11:01 -0500 (CDT)
De: "MMRF SmartBrief "
http://www.multiplemyeloma.org/

    Cancer Biol Ther. 2006 Sep 20
    Bone Complications in Multiple Myeloma
http://www.ncbi.nlm.nih.gov/entrez/...l=pubmed_docsum
Berenson JR, Rajdev L, Broder M

    Hematol Oncol. 2006 Sep 28
    Pegylated liposomal doxorubicin, melphalan and prednisone therapy for elderly patients with multiple myeloma
http://www.ncbi.nlm.nih.gov/entrez/...l=pubmed_docsum
Garcia-Sanz R, Hernandez J, Sureda A, Garcia-Larana J, Prosper F, Alegre A, Barez A, Mateos M, San Miguel J.

    Leuk Res. 2006 Sep 20
    Bortezomib therapy response is independent of cytogenetic abnormalities in relapsed/refractory multiple myeloma
http://www.ncbi.nlm.nih.gov/entrez/...l=pubmed_docsum
Chang H, Trieu Y, Qi X, Xu W, Stewart KA, Reece D.





____________
Guia de Uso - http://www.mieloma.com/v2/uso-del-foro-vf27.html

Ser feliz no significa que todo sea perfecto, quiere decir que has decidido seguir adelante pese a las dificultades.